Timely, Consistent, Transparent Assessment of Market Access Evidence: Implementing Tools Based on the HTA Core Model® in a Pharmaceutical Company

International Journal of Technology Assessment in Health Care - United Kingdom
doi 10.1017/s0266462318003653
Full Text
Abstract

Available in full text

Categories
Health Policy
Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Role of Health Technology Assessment in Pharmaceutical Market Access in Developed Countries

English

Drug Repurposing in Pharmaceutical Industry and Its Impact on Market Access: Market Access Implications

Journal of Market Access & Health Policy
2014English

Psy169 - Comparison of Eu5 Market Access Decisions for Crohn’s Disease Based on the Prismaccess® Database

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Changes in European Legislation Make It Timely to Introduce a Transparent Market Surveillance System for Cosmetics

Acta Dermato-Venereologica
DermatologyMedicine
2007English

Implementation of Technologies Based on the Evidence-Based Medicine and Hta in the Management of Hepatitis C

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

A Study on Financial Performance of Pharmaceutical Company

International Journal of Trend in Scientific Research and Development
2018English

Company Tools to Attract and Recruit Quality Workforce in the Labor Market

2019English

Sub Table Based Access Security Model (STBAM) for OLAP Tools

International Journal of Computer and Communication Engineering
2013English

Implementing Evidence-Based Programs

Health Promotion Practice
EnvironmentalPublic HealthNursingOccupational Health
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy